`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA,
`INC., and AKORN INC.
`Petitioners
`
`v.
`
`SAINT REGIS MOHAWK TRIBE and ALLERGAN, INC.
`Patent Owners
`____________________
`
`Case IPR2016-011301
`Patent 8,633,162
`____________________
`
`
`
`PETITIONER TEVA PHARMACEUTICALS USA, INC’S
` POWER OF ATTORNEY
`
`
`
`
`
`
`
`
`
`1 Cases IPR2017-00583 and IPR2017-00599 have been joined with this
`
`proceeding.
`
`
`
`IPR2016-01130
`
`US. Patent No. 8,633,162
`
`Pursuant to 37 C.F.R. § 42.10(BL—Pétitiofier‘Tmletifils—USATIM.
`
`hereby appoints the practitioners of Customer No. 26111 as its attorneys to transact
`
`all business in the United States Patent & Trademark Office and Patent Trial and
`
`Appeal Board associated with the above-captioned inter partes review of US.
`
`Patent No. 8,633,162. These practitioners include at least:
`
`Ralph Wilson Powers 111 (Registration No. 63,504)
`
`Address
`
`STERNE, KESSLER, GOLDSTEIN & Fox P.L.L.C.
`
`l 100 New York Avenue, NW
`
`Washington, DC 20005
`
`202.3 71.2600 (reception)
`
`202.371.2540 (facsimile)
`
`
`FOR: Teva Pharmaceuticals USA Inc.
`
`SIGNATURE: [W {79. '
`iii—R) {if/{~91
`
`megr-fir'g
`BY:
`TITLE: film—Ml
`
`DATE: ”/ano [la
`
`